Laure Marignol/marignol-lab.org
Aug 19, 2025, 13:17
Laure Marignol Highlights the Role of SABV in SBRT for Kidney Cancer
Laure Marignol, Professor in Radiation Biology in Trinity College Dublin, shared a post on LinkedIn:
“SBRT is an exciting option for localized kidney cancer. By integrating sex as a biological variable (SABV) into research and outcome reporting, we can build evidence that is not only stronger but also more equitable – helping ensure treatment advances benefit everyone. Check out our paper here, another example of student work from the Discipline of Radiation Therapy TCD.”
Title: Biological sex representation and reporting in stereotactic body radiotherapy for kidney cancer: A review of clinical studies
Authors: Sylvia Nwokolo, Laure Marignol
Read the Full Article at Science Direct.
More posts featuring SBRT on OncoDaily.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Sep 9, 2025, 18:18
Sep 9, 2025, 17:59
Sep 9, 2025, 17:43
Sep 9, 2025, 16:51
Sep 9, 2025, 15:59